JP2023517206A5 - - Google Patents
Info
- Publication number
- JP2023517206A5 JP2023517206A5 JP2022553675A JP2022553675A JP2023517206A5 JP 2023517206 A5 JP2023517206 A5 JP 2023517206A5 JP 2022553675 A JP2022553675 A JP 2022553675A JP 2022553675 A JP2022553675 A JP 2022553675A JP 2023517206 A5 JP2023517206 A5 JP 2023517206A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- cancer
- pharmaceutically acceptable
- linker
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062986349P | 2020-03-06 | 2020-03-06 | |
| US62/986,349 | 2020-03-06 | ||
| PCT/US2021/021201 WO2021178887A1 (en) | 2020-03-06 | 2021-03-05 | Methods, compounds, and compositions for modifying car-t cell activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517206A JP2023517206A (ja) | 2023-04-24 |
| JP2023517206A5 true JP2023517206A5 (https=) | 2024-03-14 |
Family
ID=77613014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022553675A Pending JP2023517206A (ja) | 2020-03-06 | 2021-03-05 | Ｃａｒ－ｔ細胞活性を改変するための方法、化合物、および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240058458A1 (https=) |
| EP (1) | EP4114471A4 (https=) |
| JP (1) | JP2023517206A (https=) |
| KR (1) | KR20220153027A (https=) |
| CN (1) | CN115551555A (https=) |
| AU (1) | AU2021231887A1 (https=) |
| BR (1) | BR112022017815A2 (https=) |
| CA (1) | CA3169152A1 (https=) |
| IL (1) | IL296176A (https=) |
| WO (1) | WO2021178887A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4282419A1 (en) | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| EP3439675A4 (en) | 2016-04-08 | 2019-12-18 | Purdue Research Foundation | METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY |
| WO2018160622A1 (en) | 2017-02-28 | 2018-09-07 | Endocyte, Inc. | Compositions and methods for car t cell therapy |
| US11311576B2 (en) | 2018-01-22 | 2022-04-26 | Seattle Children's Hospital | Methods of use for CAR T cells |
| AU2019225174B2 (en) | 2018-02-23 | 2025-11-20 | Endocyte, Inc. | Sequencing method for CAR T cell therapy |
| CN115210252A (zh) | 2020-02-04 | 2022-10-18 | 西雅图儿童医院（Dba西雅图儿童研究所） | 抗二硝基苯酚的嵌合抗原受体 |
| EP4644537A1 (en) | 2024-04-30 | 2025-11-05 | ConvEyXo | Targeted extracellular vesicle |
| CN121449625B (zh) * | 2026-01-06 | 2026-03-27 | 中国药科大学 | 一种靶向vista免疫检查点的荧光素探针分子及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4282419A1 (en) * | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| US20160166679A1 (en) * | 2014-12-12 | 2016-06-16 | Purdue Research Foundation | Method of treatment using folate conjugates and tyrosine kinase inhibitors |
| BR112017013981A2 (pt) * | 2015-01-26 | 2018-01-02 | Cellectis | receptores antigênicos quiméricos com uma única cadeia específicos anti-cll1 (sccars) para imunoterapia de câncer |
| US11091546B2 (en) * | 2015-04-15 | 2021-08-17 | The Scripps Research Institute | Optimized PNE-based chimeric receptor T cell switches and uses thereof |
| WO2017024318A1 (en) * | 2015-08-06 | 2017-02-09 | Dana-Farber Cancer Institute, Inc. | Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses |
| CN112543651B (zh) * | 2018-08-07 | 2023-06-02 | 普渡研究基金会 | 使car t细胞恢复活力 |
-
2021
- 2021-03-05 AU AU2021231887A patent/AU2021231887A1/en active Pending
- 2021-03-05 EP EP21765482.1A patent/EP4114471A4/en active Pending
- 2021-03-05 CN CN202180032430.XA patent/CN115551555A/zh active Pending
- 2021-03-05 WO PCT/US2021/021201 patent/WO2021178887A1/en not_active Ceased
- 2021-03-05 KR KR1020227033204A patent/KR20220153027A/ko active Pending
- 2021-03-05 BR BR112022017815A patent/BR112022017815A2/pt unknown
- 2021-03-05 IL IL296176A patent/IL296176A/en unknown
- 2021-03-05 JP JP2022553675A patent/JP2023517206A/ja active Pending
- 2021-03-05 US US17/905,748 patent/US20240058458A1/en active Pending
- 2021-03-05 CA CA3169152A patent/CA3169152A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023517206A5 (https=) | ||
| EP3057991B1 (en) | Chimeric antigen receptor t cell switches and uses thereof | |
| KR20230146528A (ko) | 암을 치료하기 위한 방법 | |
| JP2023015291A5 (https=) | ||
| ES2535742T3 (es) | Anticuerpos que se unen a CA 125/0722P asociado a células y métodos de uso de los mismos | |
| US20200188472A1 (en) | Conjugates for immunotherapy | |
| JP2022543038A (ja) | 関連づけられた抗原を有するポリマーソームの集団を、関連づけられたアジュバントを有するポリマーソームの集団と一緒に投与することによって、免疫応答を誘発する方法、およびそれら２つのポリマーソーム集団を含む組成物 | |
| BR112021002278A2 (pt) | proteínas que ligam nkg2d, cd16 e um antígeno associado a tumor | |
| CN112236149A (zh) | 用于预防和治疗细胞因子释放综合征和与免疫耗竭相关的神经毒性的去纤苷 | |
| CN112203661A (zh) | 包含双氟烷基-1,4-苯并二氮杂*酮化合物与免疫治疗剂的组合物和其使用方法 | |
| EA025182B1 (ru) | Композиция, включающая афлиберцепт, фолиновую кислоту, 5-фторурацил (5-fu) и ириноцетан (folfiri), для лечения колоректального рака | |
| JP7713390B2 (ja) | がん治療のための免疫療法 | |
| RU2007110480A (ru) | Терапевтические комбинации, содержащие ингибитор поли(адф-рибоза)полимеразы | |
| JP2021533166A (ja) | Ｃａｒ ｔ細胞の若返り | |
| AU2026201166A1 (en) | Sequencing method for CAR T cell therapy | |
| CN115551555A (zh) | 用于修饰car-t细胞活性的方法、化合物和组合物 | |
| AU2020228296B2 (en) | Administration of PD-1 inhibitors for treating skin cancer | |
| JP2023551535A (ja) | Ｔ細胞がんを治療するための方法および材料 | |
| JP2024508749A (ja) | クローンｔ細胞増殖を処置するための方法および材料 | |
| JP2022510606A (ja) | 子宮内膜症を処置するための組成物および方法 | |
| WO2021255223A1 (en) | New conjugated nucleic acid molecules and their uses | |
| TW202134278A (zh) | 用於治療腫瘤之ｅｐｈａ３導向ｃａｒ－ｔ細胞 | |
| JP2024500360A (ja) | 関連づけられた抗原および関連づけられたアジュバントを有する２つのポリマーソーム集団を投与することによる、Ｔｈ１／Ｔｈ２免疫応答の調整方法 | |
| van de Donk et al. | Dual-antigen–targeting T-cell immunotherapies in MM: circumventing tumor heterogeneity and preventing antigen escape | |
| US20250326846A1 (en) | Methods of treating cancer in immunosuppressed or immunocompromised patients by administering a pd-1 inhibitor |